Concepedia

Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: a retrospective analysis of the MAUDE database

Nauman Khalid, Toby Rogers, Evan Shlofmitz, Yuefeng Chen, Jaffar M. Khan, Anees Musallam, Micaela Iantorno, Ron Waksman

EuroIntervention · 2019 · 37 citations · 4 references

DOI

Concepts

Abstract

Robust data on the commonly reported complications and failure modes associated with Impella (Abiomed Inc, Danvers, MA) is limited. We analyzed the post-marketing surveillance data from the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database to assess these

References

4

2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care

Charanjit S. Rihal, Srihari S. Naidu, Michael M. Givertz et al. · Journal of the American College of Cardiology · 2015 · 671 citations

, , +8

The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry

William W. O’Neill, Theodore Schreiber, David Wohns et al. · Journal of Interventional Cardiology · 2013 · 387 citations · Full text

, , +17

Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device

William W. O’Neill, Cindy L. Grines, Theodore Schreiber et al. · American Heart Journal · 2018 · 228 citations

, , +9

Incidence and prognosis of vascular complications after percutaneous placement of left ventricular assist device

Miriam Abaunza, Loay Kabbani, Timothy J. Nypaver et al. · Journal of Vascular Surgery · 2015 · 91 citations · Full text

, , +9